The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 24, 2009
Filed:
Jan. 18, 2006
Alan D. Adams, Cranford, NJ (US);
A. Brian Jones, Clavering, GB;
Joel P. Berger, Hoboken, NJ (US);
James F. Dropinski, Colts Neck, NJ (US);
Alexander Elbrecht, Watchung, NJ (US);
Kun Liu, Edison, NJ (US);
Karen Lamb Macnaul, Warren, NJ (US);
Guo-qiang Shi, Monmouth Junction, NJ (US);
Derek J. Von Langen, Fanwood, NJ (US);
Gaochao Zhou, Scotch Plains, NJ (US);
Alan D. Adams, Cranford, NJ (US);
A. Brian Jones, Clavering, GB;
Joel P. Berger, Hoboken, NJ (US);
James F. Dropinski, Colts Neck, NJ (US);
Alexander Elbrecht, Watchung, NJ (US);
Kun Liu, Edison, NJ (US);
Karen Lamb MacNaul, Warren, NJ (US);
Guo-Qiang Shi, Monmouth Junction, NJ (US);
Derek J. Von Langen, Fanwood, NJ (US);
Gaochao Zhou, Scotch Plains, NJ (US);
Merck & Co., Inc., Rahway, NJ (US);
Abstract
A class of 2-aryloxy-2-arylalkanoic acids comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.